The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases.
about
Plasmatic level of neurosin predicts outcome of mild cognitive impairment.Accumulation of amyloid beta-protein in the low-density membrane domain accurately reflects the extent of beta-amyloid deposition in the brainAnalysis of beta-amyloid (Abeta) deposition in the temporal lobe in Alzheimer's disease using Fourier (spectral) analysis.Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down syndrome.Meditation and neurodegenerative diseases.Prediction of conversion from mild cognitive impairment to Alzheimer disease based on bayesian data mining with ensemble learning.Hemoglobin binding to A beta and HBG2 SNP association suggest a role in Alzheimer's diseaseA case-control study of occupational magnetic field exposure and Alzheimer's disease: results from the California Alzheimer's Disease Diagnosis and Treatment Centers.Brain imaging in dementia of the Alzheimer type.Prospective neuropathological validation of Hachinski's Ischaemic Score in dementias.Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.Material-specific memory loss in probable Alzheimer's disease.Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years.Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort.Management of neurological disorders: dementia.Cerebral blood flow and metabolism in late-life depression and dementia.Neuropathologic substrates of ischemic vascular dementia.Diagnosis, classification and natural history of degenerative dementias.Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.Protease nexin-1, an antithrombin with neurite outgrowth activity, is reduced in Alzheimer disease.Dissociation between brain amyloid deposition and metabolism in early mild cognitive impairment.MRI features of Binswanger's disease predict prognosis and associated pathologyA traditional medicinal herb Paeonia suffruticosa and its active constituent 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranose have potent anti-aggregation effects on Alzheimer's amyloid beta proteins in vitro and in vivo.White matter abnormalities and structural hippocampal disconnections in amnestic mild cognitive impairment and Alzheimer's disease.Association cortex hypoperfusion in mild dementia with Lewy bodies: a potential indicator of cholinergic dysfunction?Cognitive decline in patients with Alzheimer's disease and its related factors in a memory clinic setting, Shanghai, China.Sensitivity and specificity of neuroimaging for the diagnosis of Alzheimer's disease.Follow-up plasma apolipoprotein E levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) cohort.Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal lossCSF markers for Alzheimer's disease: total tau, phospho-tau and Abeta42.Dysfunction of the magnocellular stream in Alzheimer's disease evaluated by pattern electroretinograms and visual evoked potentials.Spectrum of neurocognitive dysfunction in Indian population on FDG PET/CT imagingDifferent patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD.Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in ADReduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patientsAstrocytes containing amyloid beta-protein (Abeta)-positive granules are associated with Abeta40-positive diffuse plaques in the aged human brainQuantitation of amyloid beta-protein (A beta) in the cortex during aging and in Alzheimer's disease.Presence of sodium dodecyl sulfate-stable amyloid beta-protein dimers in the hippocampus CA1 not exhibiting neurofibrillary tangle formationEffect of apolipoprotein E allele epsilon4 on the initial phase of amyloid beta-protein accumulation in the human brain.Fallacies in the pathological confirmation of the diagnosis of Alzheimer's disease.
P2860
Q21202048-12726E17-D2A4-43E8-B418-9BD229C10E1FQ28366524-A8617AF5-28A8-4785-8B33-44E33B5EBAF5Q30476109-2440DB64-4F61-458E-A0FA-1821FB3E3710Q30654401-1BF7949C-4F9E-4D35-83DD-695172F15A35Q30660151-665C3D3A-ECEB-4574-95C7-0B150CAFD66DQ30666491-67333BC2-A056-435E-ABF1-58A9F4DFE197Q33266027-08411C55-F423-498E-8B84-D3A4E39B9B8AQ33287246-FFEF46BA-29FF-4594-AF82-935E7EA250C2Q33432903-654C1D98-62E2-4FF4-BF53-11B0DD521ED7Q33589513-C2784B97-3376-45D7-B9F5-109540E68714Q33591798-A7D9622C-A26E-410A-93F3-30AEFAC43A02Q33592177-AFE9FB43-AE55-4966-B723-D2BBE6599D16Q33600226-A8FE3636-F021-426F-A98F-0DB7D212A1BBQ33652456-64DAE010-7AC6-482B-90CC-25A63D600127Q33733383-361AAFE6-7586-4559-9C76-752E18FC0F29Q33792248-CFA1A9E8-5438-405E-B13D-62722ABB3D3BQ34088144-EDAFE6A0-F4A6-49D5-B58B-D03789C77BF3Q34174197-2CDEFFB6-64CC-4233-83E2-E37C234C8285Q34262758-283D3D75-9398-4EB2-80B9-A022DCB28B4BQ34315031-7391CF3F-7D87-4B75-904B-2F31BE33FFA1Q34462406-8DF9D007-9C35-4438-B70D-BEA856B4CF0DQ34562869-B169313E-3106-4544-BCC3-9E36537AC520Q34982058-4F88E215-5673-49A4-B0ED-39386151E4D7Q35005133-A9A1846D-0A8E-4980-83EA-9AB95ECDACEDQ35064960-CEA1E29E-62BA-4888-94F4-25A3D13E6E74Q35154263-70475848-035E-48DB-8CE1-90C8B7BD31DDQ35236542-CAF937F0-4B17-4BFD-9880-1089A86F451DQ35342893-53012462-A4C0-4D9A-8732-76AE2062F892Q35467597-C99446CB-B250-4EF3-9765-61CBA118FDB5Q35580179-401D9A60-60AB-40A4-B660-6E7B864E4453Q35582629-F93AE0D2-971E-4180-BE5B-4DECC321324CQ35610981-83A9C952-F3A4-4E7B-8AE3-A0AF6C6A6B47Q35677181-4E19D0AE-D1D9-4DA2-88DE-F1CDB6741E7FQ35749793-356BB9EB-EDC5-4852-8F5A-4877E20AA7F6Q35749809-51B1B97C-2BC1-462F-B7E8-903B861AB441Q35764562-45A76283-B661-4F29-A69E-69AC4FFF5AE7Q35765178-45FCA9FC-36B4-4C23-BF0F-F34F4549048FQ35787262-A3E1FB3B-339A-491A-A090-4CA2E6CAF97EQ35829722-61A4DF3E-0E47-4ADE-AC79-2BF84CDC4D74Q36317646-73980688-B685-41D7-B08F-338F6488041E
P2860
The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
The NINCDS-ADRDA Work Group cr ...... opathologic study of 57 cases.
@en
The NINCDS-ADRDA Work Group cr ...... opathologic study of 57 cases.
@nl
type
label
The NINCDS-ADRDA Work Group cr ...... opathologic study of 57 cases.
@en
The NINCDS-ADRDA Work Group cr ...... opathologic study of 57 cases.
@nl
prefLabel
The NINCDS-ADRDA Work Group cr ...... opathologic study of 57 cases.
@en
The NINCDS-ADRDA Work Group cr ...... opathologic study of 57 cases.
@nl
P2093
P356
P1433
P1476
The NINCDS-ADRDA Work Group cr ...... opathologic study of 57 cases.
@en
P2093
Nieuwstraten P
Tierney MC
Zorzitto ML
P304
P356
10.1212/WNL.38.3.359
P407
P577
1988-03-01T00:00:00Z